MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Reproductive Associates of Delaware
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Three Years of IVF Results Show Positive Impact of Embryo Chromosome Testing Reports The Reproductive Associates of Delaware - Reproductive Associates of Delaware is reporting significant improvement in successful pregnancies when pre-implantation genetic screening of embryos is utilized prior to uterine transfer - IVF-DE.org
Three Years of IVF Results Show Positive Impact of Embryo Chromosome Testing Reports The Reproductive Associates of Delaware

 

NewswireToday - /newswire/ - Newark, DE, United States, 2013/02/27 - Reproductive Associates of Delaware is reporting significant improvement in successful pregnancies when pre-implantation genetic screening of embryos is utilized prior to uterine transfer - IVF-DE.org.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In vitro fertilization (IVF) outcomes from over 1,000 treatment cycles spanning 2010 through 2012 demonstrate a significant improvement in successful pregnancies when pre-implantation genetic screening (PGS) of blastocyst embryos is utilized prior to uterine transfer, reports Reproductive Associates of Delaware (RAD). PGS utilizes molecular DNA tests for the presence of normal chromosomes within embryos.

Of 416 delivered and ongoing healthy pregnancies, 68 (16%) occurred when PGS was performed. In patients over 34, PGS led to 43% of RAD's successful IVF pregnancies, and over 90% of these pregnancies occurred after single embryo transfer. When compared to IVF data published annually by the Centers for Disease Control, RAD had the highest total percentage of single embryo transfers and the lowest IVF multiple pregnancy rate in the U.S.

"Our results with IVF and PGS have clearly had an important impact on success rates, as well as increased utilization of single embryo transfer," noted Dr. Ronald F. Feinberg, IVF Medical Director at RAD. "The higher implantation and ongoing pregnancy rates with PGS are both statistically and clinically significant for patients over age 34. Most IVF clinics utilize multiple embryo transfer to enhance pregnancy rates in these patients, whereas PGS allows us to select single embryos for uterine transfer yielding a safer and higher chance of pregnancy." Embryos with abnormal chromosomes either fail to implant or commonly cause miscarriage, and are increasingly common in women over age 34.

When PGS is utilized, implantation and pregnancy rates for patients over age 34 at RAD are almost identical to the rates seen in younger women, and far surpass the rates seen in fresh non-PGS IVF transfer cycles. When PGS combined with frozen/thaw embryo transfer were carried out at RAD, the embryo implantation rates were over 60% across all ages, with a successful pregnancy rate of 56.2% and an average of 1.1 embryos transferred. The miscarriage rate was 10.5% in PGS cycles across all ages, whereas in non-PGS cycles the overall miscarriage rate was 18% in both fresh and frozen/thaw embryo transfers. Miscarriage prevention is a common indication for IVF and PGS.

"Our results suggest that PGS could prove to be highly cost-effective to help our patients maximize their singleton IVF pregnancy chances, along with much lower miscarriage risk, stated Linda Morrison, Director of Laboratory Services at RAD. "This should ultimately reduce the number of treatment cycles that many patients will need to achieve a safe and healthy pregnancy."

IVF pregnancy outcome following embryo transfer is also enhanced when the uterine environment has been optimized. During a frozen/thaw treatment cycle, the uterus has not been subjected to very high hormone levels commonly created during fresh IVF cycles. And other risks of fresh IVF transfer, such as ovarian hyperstimulation syndrome, can be virtually eliminated when frozen/thaw transfers are employed. "Recently, a respected research group at New York University published their results with PGS and single embryo transfer during frozen/thaw cycles, and demonstrated a 58% implantation rate over a four-year period," noted Dr. Feinberg. "This provides further evidence that single embryo transfer in conjunction with PGS is safe and effective."

RAD (ivf-de.org) has previously presented its IVF and PGS results at the American Society for Reproductive Medicine annual meetings. To view details of RAD's comprehensive PGS and non-PGS results for the three-year period visit the RAD website.

RAD's IVF Center, established in 1995, is part of a full service subspecialty fertility practice with locations in Newark, Wilmington, and Dover, Delaware. RAD’s Board certified physicians are Drs. Barbara McGuirk, Ronald Feinberg, George Kovalevsky, Adrienne Neithardt, and Lenore Tietjens-Grillo. RAD’s IVF, Fertility Care, and Fertility Wellness Centers are located on the main campus of the Christiana Care Health System in Newark. For more information about Reproductive Associates of Delaware visit our website.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Reproductive Associates of Delaware

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Three Years of IVF Results Show Positive Impact of Embryo Chromosome Testing Reports The Reproductive Associates of Delaware

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Kaitlyn Alexander - IVF-DE.org 
302-623-4242 kalexander[.]ivf-de.org
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Reproductive Associates of Delaware securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Reproductive Associates of Delaware / Company Profile


Read Health / Surgery Most Recent Related Newswires:

SCBIO Executive Erin Ford Appointed to South Carolina District Export Council for 2020-2021
University of the Ryukyus and NEC Discover a Novel Diagnostic Biomarker for Acute Adult T-cell Leukemia/lymphoma
Change Healthcare Recognized by Frost & Sullivan for Accelerating Claims Processing with its Intelligent Healthcare Network™ Blockchain Technology
SCBIO CEO Sam Konduros Named to South Carolina Chamber Executive Committee
Frost & Sullivan Defines Top Femtech Global Opportunities by 2024
Frost & Sullivan Highlights on Impact of the Coronavirus on Business
Global Healthcare to Soar Above Trillion in 2020 with Consumerism and Outcome-based Care Models Finds Frost & Sullivan
Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies Reports Frost & Sullivan
PointClickCare Integrated Care Coordination Platform Applauded by Frost & Sullivan
Inkwood Research Publishes Global Genetic Testing Market Forecast 2019-2027
NEC and VAXIMM Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines
Alopecia Hair Loss Treatment Market is Advancing At A CAGR of 5.51% by 2027 According to Inkwood Research
Frost & Sullivan Distinguishes Inovalon as Company of the Year for Advancing the Healthcare Industry by Harnessing Massive-Scale Data
South Carolina Life Sciences Industry Honors USC’s Dr. Harris Pastides, AVX Corporation
Neurodegenerative Disorder Therapeutics Market Sees a Silver Lining with Cell and Gene Therapies Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Limelon Advertising, Co.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)